Mirja Harms

机构：Universität Ulm, University Hospital Ulm, Technische Hochschule Ulm · ORCID：0000-0002-5460-5166

发表论文 57 篇 · 总被引 881 次 · h-index 17

代表论文

Advanced EPI-X4 Derivatives Covalently Bind Human Serum Albumin Resulting in Prolonged Plasma Stability (2022 · International Journal of Molecular Sciences · 被引 17)
Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability (2023 · Journal of Medicinal Chemistry · 被引 13)
Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection (2023 · Science Advances · 被引 12)
Fatty acid conjugated EPI-X4 derivatives with increased activity and in vivo stability (2024 · Journal of Controlled Release · 被引 10)
Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications (2023 · Journal of Medicinal Chemistry · 被引 10)
An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR–ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia (2024 · International Journal of Molecular Sciences · 被引 8)